"
Bcr-Abl-mediated Raf kinase inhibitor protein suppression promotes chronic myeloid leukemia progenitor cells proliferation"
written by Satoki Nakamura, Tomohiro Yagyu, Tomonari Takemura, Lin Tan, Yasuyuki Nagata, Daisuke Yokota, Isao Hirano, Kiyoshi Shibata, Michio Fujie, Shinya Fujisawa, Kazunori Ohnishi,
published by
Stem Cell Discovery,
Vol.1 No.3, 2011
has been cited by the following article(s):
|
[1]
|
Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma
Clinical Cancer Research,
2015
DOI:10.1158/1078-0432.CCR-15-0393
|
|
|
|
|
[2]
|
Inhibition of crosstalk between Bcr-Abl and PKC signaling by PEITC, augments imatinib sensitivity in chronic myelogenous leukemia cells
Chemico-Biological Interactions,
2015
DOI:10.1016/j.cbi.2015.10.004
|
|
|
|
|
[3]
|
FoxO3a and nilotinib-induced erythroid differentiation of CML-BC cells
Leukemia Research,
2013
DOI:10.1016/j.leukres.2013.07.001
|
|
|
|